DNA

VMX 2025: A Record-Breaking Celebration of Innovation, Education and Thought Leadership in Veterinary Medicine

Breakthroughs in veterinary medicine, immersive hands-on experiences and Academy Award-winning actor and director Kevin Costner headline the world's largest and…

1 year ago

Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill

SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…

1 year ago

Willow Launches New Pumping and Feeding Accessories to Expand Support to Breastfeeding Mothers

Mom-led company introduces new products designed for effortless breast milk collection and storage after successful 2024 growth SAN FRANCISCO, Jan.…

1 year ago

Liberation Labs Closes $50.5 Million Convertible Note

Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond,…

1 year ago

Precision AQ Launches Navigator365™ Matrix, an Advanced Platform for Identifying Digital Opinion Leaders to Activate and Amplify Brand Messages

The latest addition to the Navigator365™ Omnichannel product family transforms how life sciences companies engage with digital influencers through actionable insights…

1 year ago

Myriad Genetics Unveils Groundbreaking Eight Weeks’ Gestation NIPT Study Results at Society for Maternal-Fetal Medicine Conference

Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.…

1 year ago

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer…

1 year ago

PolyPid to Report Fourth Quarter and Full-Year 2024 Financial Results and Operational Highlights on February 12, 2025

PETACH TIKVA, Israel, Jan. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming…

1 year ago

Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+…

1 year ago

Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th

Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that…

1 year ago